Aptus Pharma Ltd.

Financial

	Aptus Pharma	Zota Health Care	Sunrest Lifescience
Operational Metrics
Financials
5 yr Average ROE	36.58 %	-7.74 %	44.85 %
5yr average Equity Multiplier	5.05	1.84	19.93
5yr Average Asset Turnover Ratio	1.72	0.91	1.65
5yr Avg Net Profit Margin	6.16 %	-4.95 %	2.65 %
Price to Book	n/a	19.59	0.0
P/E	n/a	0.0	10.12
5yr Avg Cash Conversion Cycle	88.73 Days	40.5 Days	102.32 Days
Inventory Days	64.83 Days	91.82 Days	33.02 Days
Days Receivable	65.8 Days	42.2 Days	160.04 Days
Days Payable	77.01 Days	92.36 Days	160.27 Days
5yr Average Interest Coverage Ratio	6.23	5.98	116.4
5yr Avg ROCE	28.46 %	-2.72 %	20.04 %
5yr Avg Operating Profit Margin	10.95 %	3.69 %	4.4 %
5 yr average Debt to Equity	2.26	0.04	5.91
5yr CAGR Net Profit	74.79 %	206.06 %	41.88 %
5yr Average Return on Assets	8.44 %	-3.4 %	4.29 %
Shareholdings
Promoter Holding	n/a	57.42 %	69.91 %
Share Pledged by Promoters	n/a	0.26 %	0.0
Change in Promoter Holding (3 Yrs)	n/a	-10.7 %	0.0
Change in Mutual Fund Holding (3 Yrs)	n/a	0.0	0.0

Business

	Aptus Pharma	Zota Health Care	Sunrest Lifescience
Product Wise Break-Up	Product Wise Break-Up Finished Formulations 94.44 Commission 5.56 Retail Pharmacy 0 Export 0 0	Product Wise Break-Up Marketing 21.65 Export 10.89 Commission 0 Finished Formulations 0 Pharmacy 63.56 Others 3.9	Product Wise Break-Up 0 Export 0 Commission 0 Finished Formulations 0 Retail Pharmacy 0 Others 100
Location Wise Break-Up	Location Wise Break-Up Gujarat 99.2 West bengal 0.8 Rest of the World 0 India 0	Location Wise Break-Up Rest of the World 6.41 West bengal 0 India 93.59 Gujarat 0	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti Infective 29.4 Anti-Allergy & Respiratory 19.6 Antacids and Gastrointestinal 17.2 Anti Inflammatory & Pain Management 10.0 Supplement 5.6 Others 18.2	-	-